Artiz

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Artiz

Quick Facts

Property Description
Active Ingredient Cetirizine Hydrochloride
Form Tablets, Syrup, Oral Solution
Pharmacological Class Second-Generation Antihistamine
Common Use Relief of allergic symptoms
Origin Synthetic (Metabolite of Hydroxyzine)

What Type of Medicine is Artiz and How is it Classified?

Artiz is a pharmacological preparation whose active ingredient is Cetirizine Hydrochloride, which is classified as a Second-Generation Antihistamine. This compound functions as a selective peripheral histamine H1-receptor antagonist. It is widely available for oral administration as an Over-The-Counter (OTC) medication, suitable for managing allergic responses in both Adults and Children. This classification is key to its generally non-sedating profile, a property resulting from its limited capacity to cross the blood-brain barrier. It serves as an agent in managing allergic rhinitis and chronic urticaria.

Cetirizine Hydrochloride: Composition, Origin, and Forms

The fundamental composition of Artiz relies on Cetirizine Hydrochloride, a synthetic compound derived as a metabolite of the first-generation agent, Hydroxyzine. The substance exists as a racemic compound, containing a mixture of two mirror-image chemical structures. Cetirizine Hydrochloride primarily targets peripheral H1-receptors, which facilitates its selective anti-allergic action. Artiz is specifically positioned to offer its anti-allergic effects in various user-friendly Pharmaceutical Preparations for Oral use, including traditional Tablets and palatable Syrup forms, and is considered a single-component drug.

What is the General Purpose of Artiz?

The general purpose of Artiz is to provide sustained relief from the symptoms of allergic reactions, such as those experienced during hay fever season. As an H1-Receptor Antagonist, the preparation directly blocks the receptors where Histamine binds, thereby interrupting the biochemical events that lead to typical allergy discomforts. This targeted action allows Artiz to deliver reliable anti-allergic effects suitable for managing daily exposure to environmental allergens.

What side effects are possible with Artiz?

The official safety profile for Artiz (Cetirizine Hydrochloride) defines its possible side effects and safety constraints based on clinical and post-marketing data collected by regulatory authorities.

Documented Adverse Reaction Categories

Adverse reactions are classified by frequency, with the most commonly reported effects involving the Nervous System and Gastrointestinal System. Effects classified as common (occurring in 1/100 to < 1/10 individuals) include somnolence (drowsiness), headache, dizziness, fatigue, dry mouth, and nausea. Less frequent effects, such as paresthesia (numbness/tingling) and abdominal pain, are categorized as uncommon.

Reactions classified as rare (1/10,000 to < 1/1,000) include tachycardia (increased heart rate), abnormal liver function (transaminase elevation), and agitation. Very rare events include Anaphylactic Shock, severe hypersensitivity, and blurred vision.

Safety Considerations and Constraints

The official labeling notes specific safety constraints for certain patient groups. Individuals with severe renal impairment (creatinine clearance < 10 ml/min) have a documented contraindication to use, and a reduced dose is noted as necessary for patients with less severe renal impairment. Caution is advised for older adults due to the likelihood of decreased renal function.

Regarding high-level safety consequences, concomitant use with alcohol or other Central Nervous System (CNS) depressants may result in additional impairment of performance and reduced alertness. Furthermore, the label documents reports of pruritus (severe itching) and urticaria appearing upon discontinuation of the medication, representing a time-related safety pattern, particularly following long-term use.

Overdose and Emergency Response

Artiz (Aripiprazole) Overdose and When to Seek Help

An overdose of Artiz (aripiprazole) may cause a range of symptoms, primarily related to the drug’s effects on the central nervous and cardiovascular systems. Because aripiprazole has a long elimination half-life, symptoms may be prolonged, and extended monitoring is often necessary.

Symptoms of Overdose

The most commonly reported symptom of an overdose is sedation or unusual drowsiness, which can progress to coma in severe cases. Other signs may include:

  • Cardiovascular Changes: Tachycardia (fast heartbeat) and hypotension (low blood pressure).
  • Neurological Effects: Seizures, extrapyramidal symptoms (involuntary muscle movements, tremor, restlessness), miosis (pinpoint pupils), and confusion.
  • Gastrointestinal Distress: Nausea and vomiting.

When to Seek Immediate Medical Help

Always treat a suspected overdose as a medical emergency. Immediately call local emergency services or a poison control center if you or someone else has taken more Artiz than prescribed, even if there are no immediate symptoms. Do not wait for severe symptoms to appear.

Seek emergency care right away if the individual:

Symptom Category Signs to Look For
Consciousness Becomes difficult to arouse, loses consciousness, or has a seizure.
Breathing Experiences shallow breathing or has trouble breathing.
Cardiac Has a very fast, pounding, or irregular heartbeat.

Treatment for overdose is supportive and should be conducted under close medical supervision.

Therapeutic Uses of Artiz

Artiz, containing Cetirizine Hydrochloride, is commonly used in situations involving certain distressing symptoms linked to allergic conditions.

Symptomatic Relief for Allergic Rhinitis and Hives

Artiz is primarily used for symptomatic relief of allergic conditions, including seasonal hay fever, perennial allergic rhinitis, and the recurrent discomfort of Chronic Idiopathic Urticaria (CIU), commonly known as chronic hives. It helps address symptom clusters that may become intense or disruptive, including sneezing, runny nose (rhinorrhea), nasal and ocular itching, and the formation of raised welts or weals. The medication provides supportive relief when symptoms interfere with routine activities.

“The medication offers supportive relief that helps ease the overall symptom burden, supporting patients during episodes of heightened discomfort.”

The therapeutic benefit supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load during symptomatic periods. It is relevant in contexts involving heightened systemic burden and is commonly used across patient groups, including adults and children, for managing these common allergic presentations.


Quick Fact: Relief for Pruritus (Itching)

Artiz is relevant for easing the intense pruritus associated with allergic skin reactions and hives, and may assist with maintaining functional stability when symptoms are more noticeable.

Regulatory References

  1. National Institutes of Health (NIH) StatPearls

Eligibility and Restrictions for Use

Who Can and Cannot Use Artiz?

This section outlines the official population eligibility and non-eligibility rules for Artiz (Cetirizine Hydrochloride), as documented in governmental regulatory sources. Eligibility is defined by absolute contraindications, age limitations, and the patient’s underlying medical conditions, such as organ function.


Absolute Contraindications

Artiz is contraindicated (must not be used) in patients who have:

  • A known hypersensitivity or allergic reaction to Cetirizine Hydrochloride or its parent compound, Hydroxyzine.
  • Severe Renal Impairment, typically defined as a Creatinine Clearance (CrCl) of less than 10 mL/min.

Population Eligibility and Restrictions

Population Group Regulatory Status Notes on Use
Adults and Adolescents ( ge 12 years) Generally Approved Standard use for approved conditions.
Children (6 months to 11 years) Approved (Oral Forms) Safety and efficacy are Not Established for infants le 6 months of age.
Renal/Hepatic Impairment Restricted Use Patients with diminished renal function require a dose adjustment (reduction). Use is not recommended in young children with impaired function.
Pregnancy Caution Should Be Exercised Use is advised only if clearly needed due to limited data.
Lactation (Breastfeeding) Not Recommended The medicine is excreted into human milk, and use is generally not recommended.
Geriatric Patients ( ge 65 years) Restricted Use Use requires caution, and dose adjustment is necessary if renal function is reduced.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Artiz (Cetirizine Hydrochloride) is defined by its pharmacokinetic clearance and pharmacodynamic additive effects, based strictly on government regulatory documents.

Documented Interaction Patterns

Category Interacting Substance/Condition Official Interaction Statement
Pharmacodynamic Alcohol and CNS Depressants Co-administration may cause additional reductions in alertness and further impairment of performance due to additive depressant effects.
Pharmacokinetic Theophylline (400 mg once daily) Co-administration results in a 16% decrease in the clearance of cetirizine, although the disposition of Theophylline is not altered.
Pharmacokinetic Food Does not reduce the overall extent of absorption (AUC), but the rate of absorption is decreased, leading to a lower peak plasma concentration (C max). No mandatory timing separation is stipulated.

Official Regulatory Restrictions

Artiz is substantially excreted unchanged by the kidney. Therefore, use is contraindicated in patients with end-stage renal disease (eGFR below 15 mL/min) due to the risk of accumulation. Dosing adjustments are required for patients with mild, moderate, or severe renal impairment, and caution is recommended in patients with hepatic impairment.

Mechanism of Action

Targeting the Histamine H1 Pathway

Artiz's primary biological action is to function as a selective antagonist by binding with high affinity to peripheral Histamine H1 receptors . This targeted interaction prevents the natural signaling chemical, histamine, from attaching to the receptor, thereby suppressing the initial intracellular molecular cascade. This antagonism results in the inhibition of immediate physiological effects typically mediated by H1 receptor activation, primarily in vascular and nerve tissues.

Influence on Vascular Permeability and Cellular Recruitment

The central action of H1 receptor blockade results in key physiological changes, including a reduction in capillary permeability (leakage) and a decrease in the excitation of sensory nerves. This mechanism also influences pathways that affect the sustained recruitment and migration of inflammatory cells (such as eosinophils) into the tissue. These combined mechanistic steps result in the suppression of multiple components of the H1-mediated physiological reaction.

Dosage and Administration Information

Instruction Map: How to use Artiz — administration guidelines

Administration scope

Feature Guidance
Route of administration Oral (Tablet, Orally Disintegrating Tablet, or Oral Solution)
Dosing schedule Typically, 10 mg to 15 mg once daily. The maximum daily dose should not exceed 30 mg.
Timing in relation to meals (if applicable) Administer orally once daily without regard to meals.
Preparation requirements (if applicable) Oral Solution: Use a dedicated measuring device (oral syringe or dosing cup) to ensure accurate dosing. Orally Disintegrating Tablet: Use dry hands to remove from the foil; allow to dissolve completely on the tongue.
Age-group administration rules Adolescents (13 years and older): Initial daily dose of 2 mg, titrated up to 10 mg. Patients with known CYP2D6 Poor Metabolizer status: Administer half of the usual dose.
Missed-dose rules If a dose is missed, take it as soon as it is remembered. Do not take a double dose to compensate for the missed dose; resume the regular dosing schedule.
Special procedural conditions Oral Tablet: Swallow the tablet whole; do not divide, crush, or chew. Dosage increases should generally not be made before two weeks of treatment.

Instruction classifications (high-level)

Classification Detail
Administration method type Oral
Frequency pattern Daily (Once-a-day schedule)
Basis Established standards for Cetirizine Hydrochloride
Use-context constraints Dosage adjustments are required for patients with co-administration of strong CYP3A4 or CYP2D6 inhibitors or inducers.

Resulting procedural structure

Step sequence:

  • Take the prescribed Artiz formulation (tablet, solution, or disintegrating tablet) once daily.
  • Administer the dose at the same time each day, with or without food.
  • If using the oral solution, measure the exact dose using the provided measuring device; avoid using household spoons.
  • For adolescents, treatment initiation begins with a low dose (e.g., 2 mg) and gradually increases over several days to the recommended target dose.

Connection to the overall use protocol:

The Artiz use protocol establishes the Oral route as the primary administration method, to be followed Once Daily without imposing dietary restrictions. The instructions outline precise dosing rules, including specific dosage requirements for pediatric patients and those with known metabolic status changes (CYP2D6 Poor Metabolizers), alongside clear guidance on managing a missed daily dose to prevent accidental doubling.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Artiz (Cetirizine Hydrochloride)


Evidence for Use in Seasonal Allergic Rhinitis (SAR)

The research conducted for seasonal allergic rhinitis mainly involved Randomized Controlled Trials (RCTs) that was studied for both Adults and Adolescents and dedicated studies for Children. These studies were conducted during periods of increased symptom activity and research examined outcomes related to physical discomfort. Researchers primarily used a Total Symptom Score (TSS), which is a patient-reported measure of outcomes describing episodic changes in symptoms like sneezing, runny nose, and itching in the eyes and nose.

Findings describe patterns observed in the studied populations related to these symptom axes. Studies report how symptoms evolved in the observed populations, and the evidence contributes to understanding symptom patterns associated with acute or disruptive episodes.

Evidence for Use in Chronic Hives (Chronic Idiopathic Urticaria, CIU/CSU)

The evidence for Chronic Hives, or Chronic Idiopathic Urticaria, was evaluated in studies related to outcomes related to physical discomfort using Randomized Controlled Trials and specialized Crossover Studies. This research was applied in studies examining symptom intensity or variability in populations of Adults and Adolescents, as well as some Children. Studies explored specific patient-reported outcomes describing perceived discomfort, focusing on Weal and Itch severity scores.

For the higher-dose research scenario, evidence is limited and often involves studies where sample sizes were modest. Consequently, the overall certainty remains low for outcomes related to non-standard dosing.


What is Still Uncertain About the Research for Artiz

The evidence highlights what is known and what is still uncertain regarding the studies, which points to areas where research is ongoing or data are still emerging. The long-term effects of management for either allergic rhinitis or chronic urticaria are not fully established beyond the typical follow-up durations of the major trials. Overall, the results apply only to the populations studied in the short-term trials, and research provides context but not individual predictions regarding outcomes over many years of use.

Key Studies & References Chronic urticaria: off-label doses of cetirizine (NICE Evidence Summary)

Frequently Asked Questions (FAQ)

Common questions about Artiz (FAQ)

Q: How quickly should I expect to feel the effects of Artiz?

A: Official information from clinical studies indicates that the antihistaminic effect began in a majority of tested subjects within the first hour. Following a single dose, the effect was observed in 50% of tested subjects within 20 minutes and in 95% of subjects within one hour, with the activity persisting for at least 24 hours.

Q: Is Artiz considered a strong medication?

A: Artiz is classified as a Second-Generation Antihistamine, which means it primarily targets peripheral histamine receptors. This mechanism is common for agents used in managing allergic responses.

Q: Can Artiz cause weight gain or weight loss?

A: Official adverse reaction reports indicate that weight gain has been reported as an uncommon side effect in some post-marketing surveillance. Weight changes are not listed among the most frequently reported side effects in the main clinical trials.

Q: What's the main difference between Artiz and other similar drugs I see advertised?

A: The active ingredient in Artiz is a selective H1-receptor antagonist. Regulatory documents note that it has limited capacity to cross the blood-brain barrier. This property is the mechanistic basis for its often less-sedating profile compared to older, first-generation antihistamines.

Q: Can elderly patients safely take Artiz?

A: Regulatory documents indicate that use of Artiz in older adults requires caution. Due to the higher likelihood of decreased kidney function in this population, a reduced dose may be necessary. Furthermore, use is generally contraindicated or requires restriction if kidney function is severely impaired.

Q: Is Artiz safe for long-term use?

A: Official regulatory documents do not set a limit on the duration of use for Artiz. However, post-marketing reports note that some individuals experienced severe itching (pruritus) and hives (urticaria) upon stopping the medication, particularly following daily, long-term use. This emphasizes the need for careful management.

Q: What should I do if I miss a dose of Artiz?

A: Official instructions state that if a dose is missed, it should be taken as soon as it is remembered. Regulatory guidance advises not to take a double dose to make up for the missed one, but rather to continue with the regular dosing schedule.

Q: Does Artiz need to be taken with food, or can I take it on an empty stomach?

A: According to official regulatory labeling, Artiz may be taken with or without food. While food may slightly slow the rate at which the medication is absorbed, it does not change the overall amount of medicine absorbed by the body.

Q: Can Artiz affect my sleep patterns?

A: The official product information lists somnolence (drowsiness) as a common side effect. Additionally, insomnia (difficulty sleeping) has been noted in rare post-marketing reports, indicating a potential effect on sleep and wakefulness.

Q: Will Artiz make me feel dizzy or drowsy?

A: Regulatory documents state that dizziness and drowsiness (somnolence) are documented as common side effects, meaning they occur in 1/100 to < 1/10 individuals. Patients should be aware of these potential effects.

Q: Is Artiz a controlled substance?

A: No, the active ingredient in Artiz (Cetirizine Hydrochloride) is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA). It is widely available without the restrictions typically placed on controlled substances.

Q: Are the side effects of Artiz permanent?

A: The majority of common adverse reactions, such as dry mouth and drowsiness, are generally transient, meaning they are temporary and resolve over time or upon discontinuation of the medicine. Very rare, serious events are exceptions that require immediate medical intervention.

Q: Why do doctors prescribe Artiz instead of Drug X (a common alternative)?

A: Artiz is a highly selective peripheral H1-receptor antagonist. It is prescribed because its targeted mechanism of action is indicated for the treatment of specific allergic conditions, such as seasonal allergic rhinitis and chronic idiopathic urticaria.

Q: How long does Artiz stay in your system after stopping it?

A: Official pharmacokinetic data indicates that the average plasma elimination half-life of Artiz in healthy adults is approximately 8.3 hours. This half-life refers to the time it takes for the amount of medicine in the blood to decrease by half.

Q: Does Artiz show up on a standard drug test?

A: Since Artiz is not classified as a controlled substance, its active ingredient, Cetirizine, is not typically screened for on standard employment drug panels (e.g., 5-panel or 10-panel tests).

Q: Can Artiz be taken by people with high blood pressure?

A: Artiz (Cetirizine alone) does not have high blood pressure listed as a contraindication. However, combination products that include a decongestant alongside Cetirizine often do carry specific warnings and restrictions for patients with high blood pressure.

Q: Does Artiz interact with herbal remedies like St. John's Wort?

A: No formal regulatory drug interaction study specifically with St. John's Wort is listed in the core labels. However, because both substances can potentially affect the nervous system, caution is generally advised when combining with any substance that may cause dizziness or drowsiness.

Q: Why is Artiz prescribed in different strengths?

A: Official labeling states that Artiz is available in different strengths (e.g., 5 mg and 10 mg tablets) to accommodate various dosing needs. This is to facilitate appropriate dosage for different indications and for specific populations like individuals with impaired organ function.

Q: What if I take too much Artiz by accident?

A: Official instructions state that in case of a suspected overdose, the poison control helpline should be called immediately or emergency medical help sought. Symptoms of overdose may include restlessness, irritability, and drowsiness.

Q: Does Artiz have a known interaction with caffeine?

A: Regulatory documents do not list a clinically significant interaction between Artiz and caffeine. However, since Artiz is known to cause drowsiness, combining it with stimulants may potentially mask these sedative effects.

Q: Does Artiz affect fertility?

A: There are no controlled studies on the effects of Artiz on human fertility. However, in non-clinical toxicology testing, animal studies have generally failed to show evidence of harmful effects on fertility when the active ingredient was administered at high doses.

Q: Do I need regular blood tests while taking Artiz?

A: Routine laboratory monitoring is not generally required for Artiz during normal therapeutic use. Nevertheless, the official label notes that temporary elevations of liver enzymes have been reported rarely, and blood monitoring may be considered if liver function is a concern.

Q: Does Artiz interfere with birth control pills?

A: Official regulatory documents and the product label for Artiz do not list a documented drug interaction with oral contraceptive pills (birth control pills).

Q: Can Artiz cause mood changes or anxiety?

A: Official adverse event documents list agitation as a rare side effect, and confusion as a very rare event. Restlessness has also been reported in cases of overdose, which may be perceived as mood changes.

Q: How do I know if Artiz is working for me?

A: Effectiveness is typically measured by the relief of specific allergy symptoms. Improvement in symptoms like sneezing, runny nose, itchy eyes, and hives is consistent with the outcomes observed in clinical trials, which indicates the medicine is functioning as intended.

Q: Is Artiz more effective for certain groups of people?

A: Official studies established the effectiveness of Artiz across Adults, Adolescents, and Children for approved uses. However, specific dosage adjustments are required for all individuals with known impaired kidney or liver function.

Q: Does Artiz change how my body metabolizes other medicines?

A: Artiz is primarily excreted unchanged by the kidney and is metabolized to a very limited extent. It is not metabolized by the major cytochrome P450 systems, which means it is less likely to significantly affect the metabolism of many other medicines.

Q: Can Artiz make my existing medical condition worse?

A: Artiz is contraindicated (must not be used) in patients with severe kidney impairment. Caution is also officially advised for individuals with a predisposition to urinary retention and those with epilepsy or a risk of convulsions. Caution is advised for these populations as the official label suggests a potential risk of exacerbating these specific conditions.

How should Artiz be stored and disposed of?

Artiz must be stored according to the requirements specified in official government labeling for its active ingredient, Cetirizine Hydrochloride.

Storage Requirements

Condition Official Regulatory Statement
Temperature Store at Controlled Room Temperature (20°C to 25°C or 68°F to 77°F).
Environmental Protect from light, avoid high humidity, and excessive heat (above 40°C).
Container Keep the medicine in its container, tightly closed. Do not use if the safety seal is broken or missing.
Child Safety Mandatory instruction: Keep out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired Artiz must follow federal guidelines. The preferred option is a drug take-back program. If a take-back site is unavailable, the medicine must not be flushed. Instead, remove the medicine from the container, mix it with an undesirable substance (like dirt or used coffee grounds), seal the mixture in a separate bag or container, and place it in the household trash. Scratch out all personal information on the original packaging before discarding it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Artiz found in:

A-Z Index: